Journal profile · Urology & Nephrology
Urologia Internationalis
ISSN 0042-1138 · eISSN 1423-0399 · S. Karger AG · SWITZERLAND · Bimonthly · Founded 1955
Urologia Internationalis: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.25; hybrid open access; APC charged, amount not published; median 97 days to acceptance (107 articles, last 24 months); community-reported acceptance: easy; 99 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Urologia Internationalis is published by S. Karger AG and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Urinary Bladder and Prostate Research, Urological Disorders and Treatments and Bladder and Urothelial Cancer Treatments, together about 25.6% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Concise but fully substantiated international reports of clinically oriented research into the science and current management of urogenital disorders form the nucleus of original as well as basic research papers. These are supplemented by up-to-date reviews by international experts on the state of the art of key topics of clinical urological practice. Essential topics receiving regular coverage include the introduction of new techniques and instrumentation as well as the evaluation of new functional tests and diagnostic methods. Special attention is given to advances in new surgical techniques and clinical oncology. The regular publication of selected case reports represents the great variation in urological disease and illustrates treatment solutions in singular cases.
From the journal's Aims & Scope
Research area (LetPub): Urology & Nephrology
Editor-in-chief Maximilian BurgerPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Urinary Bladder and Prostate ResearchMedicine9.6%
- Urological Disorders and TreatmentsMedicine8%
- Bladder and Urothelial Cancer TreatmentsMedicine8%
- Prostate Cancer Diagnosis and TreatmentMedicine7.3%
- Kidney Stones and Urolithiasis TreatmentsMedicine7%
- Pelvic floor disorders treatmentsMedicine5.7%
- Pediatric Urology and Nephrology StudiesMedicine5.3%
- Urinary and Genital Oncology StudiesMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.25LetPub ·
- Impact factor (publisher)
- 1.2Publisher website ·
- CiteScore 2026-06
- 3.3LetPub ·
- CiteScore (publisher)
- 3.3Publisher website ·
- SJR 2026-06
- 0.49LetPub ·
- SNIP 2026-06
- 0.8LetPub ·
- h-index
- 48LetPub ·
- h-index
- 83OpenAlex ·
- i10-index
- 3,067OpenAlex ·
- 2-year mean citedness
- 1.28OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 21.03%LetPub ·
Volume
- Articles per year
- 95LetPub ·
Articles by year OpenAlex count · 8,153 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 67 | 21 | 8 |
| 2025 | 99 | 25 | 111 |
| 2024 | 107 | 35 | 230 |
| 2023 | 110 | 46 | 418 |
| 2022 | 115 | 38 | 665 |
| 2021 | 247 | 64 | 2,287 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
97 daysMedian, submission to acceptance · P25–P75 58 days – 131 days
- Acceptance to online
- median 22 days (107 articles)
- Submission to online
- median 119 days
- Sample
- 107 articles with submission and acceptance dates (235 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to final decision
- 42 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- S. Karger AG
- Country or region
- SWITZERLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1955
- ISSN
- 0042-1138
- Electronic ISSN
- 1423-0399
- Latest issue on the website
- Volume 110, Issue 4 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Urologia Internationalis
What CAS zone is Urologia Internationalis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Urologia Internationalis is in Zone 4 of Medicine, and in Zone 4 of the minor category Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Urologia Internationalis?
The latest impact factor listed by LetPub is 1.25; CiteScore 3.3, h-index 83.
How long does peer review take at Urologia Internationalis?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 97 days (interquartile range 58–131 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Urologia Internationalis?
According to LetPub and DOAJ records, Urologia Internationalis is indexed in SCIE and Scopus.
Is Urologia Internationalis open access, and what is the APC?
Urologia Internationalis is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .